A new study from Israel shows that a fourth coronavirus vaccine shot for patients over 60 significantly reduces the patient’s likelihood of having a serious case of Covid if they get infected, Reuters reports.
After a fourth dose, patients over the age of 60 had developed immunities twice as strong as those in people who had only received three doses. The Pfizer/BionTech vaccine was the one used in the study.